Study points to need for Group B Strep vigilance in newborns

03/21/2013 | Minnesota Public Radio

Health experts in Minnesota are expressing concern regarding an increase in cases of a drug-resistant form of Group B Streptococcus called serotype IV. The strain made up 16% of neonatal cases in 2010, according to a study published in the CDC journal Emerging Infectious Diseases. Researcher Dr. Patricia Ferrieri highlighted the importance of watching for signs of drug-resistant Group B Strep in an infant's first days of life.

View Full Article in:

Minnesota Public Radio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA